Key result
Peripheral endothelial dysfunction fails to correlate with coronary microvascular dysfunction in ANOCA.
Why the study?
The association between peripheral endothelial dysfunction and coronary microvascular dysfunction in women with angina and no obstructive CAD was unclear.
Are impaired flow-mediated dilation and plasma biomarkers associated with coronary microvascular dysfunction in women with angina and no obstructive CAD?
Cross-Sectional (n=219)
Are impaired flow-mediated dilation and plasma biomarkers associated with coronary microvascular dysfunction in women with angina and no obstructive CAD?
Peripheral endothelial function assessed by FMD does not correlate with coronary microvascular dysfunction in women with INOCA, indicating peripheral testing cannot substitute for coronary flow assessment.
Answers are grounded in this paper and cite their sources.
Peripheral FMD testing should not substitute for coronary assessment in INOCA; leaves open distinct endothelial pathways.
PURPOSE: We investigated whether impaired flow-mediated dilation (FMD) and plasma biomarkers reflecting endothelial dysfunction are associated with coronary microvascular dysfunction (CMD) in women with angina and no obstructive coronary artery disease (CAD). METHODS: Patients (n = 194) were randomly selected women with angina pectoris and no obstructive CAD (<50% stenosis). A reference population of asymptomatic women without CAD (n = 25) was included. We measured FMD in the brachial artery by high-resolution ultrasound. Coronary flow velocity reserve (CFVR) was assessed by transthoracic Doppler flow echocardiography (TTDE) of the left anterior descending artery during rest and high-dose dipyridamole infusion. CMD was defined as CFVR <2. RESULTS: FMD and CFVR were measured in 128 patients and 21 controls. Mean (SD) age was 64.5 (8.9) years, mean CFVR was 2.3 (2.0-2.7), and mean FMD was 8.4% (4.8%) in angina patients. Angina patients had a higher risk factor burden compared with the reference population. Measures of peripheral endothelial dysfunction and endothelial plasma biomarkers did not differ according to angina or CFVR. CFVR and FMD did not correlate (Spearman ρ = -0.07, p = 0.45). CONCLUSIONS: FMD and biomarkers of endothelial dysfunction did not identify individuals with CMD assessed as impaired CFVR by TTDE in women with angina and no obstructive CAD.
No takes yet. Share an insight, caveat, or question.
Raft et al. (2017) conducted a cross-sectional in Angina and no obstructive coronary artery disease (n=219). Impaired flow-mediated dilation (FMD) and plasma biomarkers was evaluated on Correlation between coronary flow velocity reserve (CFVR) and flow-mediated dilation (FMD) (Spearman ρ = -0.07, p=0.45). Flow-mediated dilation and biomarkers of endothelial dysfunction did not correlate with coronary flow velocity reserve in women with angina and no obstructive CAD.
Synapse has enriched 10 related papers. Consider them for comparative context: